Role of mitogen-activated protein kinase cascades in P2Y receptor-mediatedtrophic activation of astroglial cells

Citation
Jt. Neary et al., Role of mitogen-activated protein kinase cascades in P2Y receptor-mediatedtrophic activation of astroglial cells, DRUG DEV R, 53(2-3), 2001, pp. 158-165
Citations number
53
Categorie Soggetti
Pharmacology & Toxicology
Journal title
DRUG DEVELOPMENT RESEARCH
ISSN journal
02724391 → ACNP
Volume
53
Issue
2-3
Year of publication
2001
Pages
158 - 165
Database
ISI
SICI code
0272-4391(200106/07)53:2-3<158:ROMPKC>2.0.ZU;2-L
Abstract
The trophic actions of extracellular nucleotides and nucleosides on astrogl ial cells in the central nervous system may be important in development as well as injury and repair. Here we summarize recent findings on the signal transduction mechanisms and gene expression that mediate the trophic effect s of extracellular ATP on astrocyte cultures, with a particular emphasis on mitogenesis. Activation of ATP/P2Y receptors leads to the stimulation of m itogen-activated protein kinase (MAPK) cascades, which play a crucial role in cellular proliferation, differentiation, and survival. Inhibition of ERK and p38, members of two distinct MAPK cascades, interferes with the abilit y of extracellular ATP to stimulate astrocyte proliferation, thereby indica ting their importance in mitogenic signaling by P2Y receptors. Signaling fr om P2Y receptors to ERK involves phospholipase D and a calcium-independent protein kinase C isoform, PKC; this pathway is independent of the phosphati dylinositol-phospholipase C / calcium pathway which is also coupled to P2Y receptors. Pharmacological studies suggest that astrocytes may express an a s-yet uncloned P2Y receptor that recruits a novel MEK activator in the ERK cascade. Extracellular ATP can also potentiate fibroblast growth factor (FG F)-2-induced proliferation, and studies on interactions between ATP and FGF -2 signaling pathways have revealed that although ATP does not activate cRa f-1, the first protein kinase in the ERK cascade, it can reduce cRaf-1 acti vation by FGF-2. As intermediate levels of Raf activity stimulate the cell cycle, the partial inhibition of FGF-incluced Raf activity by ATP may contr ibute to the enhancing effect of ATP on FGF-2-induced astrocyte proliferati on. Activation of P2Y receptors also leads to nuclear signaling, and the us e of DNA arrays has shown that treatment of astrocytes with extracellular A TP results in the up- and downregulation of a number of genes; studies to d etermine which of these genes are regulated by MAPKs are now in progress. E lucidation of the components of MAPK pathways linked to P2Y receptors and s ubsequent changes in gene expression may provide targets for a new avenue o f drug development aimed at the management of astrogliosis which occurs in many types of neurological disorders and neurodegeneration. Published 2001 Wiley-Liss, Inc.